BofA: AI Productivity Lag Favors Value Stocks, Biotech & Commodities

Nashnova编辑部
Published todayAbout 10 min read

BofA's Aug 12 report finds U.S. corporate capex at a record high yet AI has not delivered the expected productivity leap, prompting the firm to recommend diversifying into value stocks, biotech and commodities.

01

Companies are spending record sums on AI — why hasn't productivity moved?

S&P 500 non-financial capex as a share of sales has hit an all-time high, yet U.S. productivity growth runs at just 2.2% annually — barely above the 2% long-run average since 1987.
BofA economists estimate AI adds roughly 0.1 percentage point per year to productivity, held back by slow adoption, skill shortages and organizational barriers.
This means → the internet era (1996–2004) saw clear productivity acceleration alongside tech spending; that pattern has not repeated with AI so far.
BofA also warns: AI's biggest long-term gains may flow to consumers and the broader economy, not to the companies funding the infrastructure.
02

Semiconductors are overcrowded — where should capital rotate?

BofA's fund-manager survey shows semis remain the most crowded trade; July net inflows into semiconductor ETFs hit $17 billion.
The committee flags four alternatives with low AI-cycle dependence: biotech, insurance, regional banks and revenue-weighted small caps — each returning roughly 10% or more since June.
In plain terms = the AI-hardware trade is packed shoulder-to-shoulder; BofA says step out and look where the crowd hasn't gathered.
03

Value stocks and international small caps — what do the numbers say?

International small-cap value has returned 98% over five years, beating U.S. large-cap growth at 85%; it trades at roughly 12× forward earnings versus about 30× for U.S. large-cap growth.
Tech-sector exposure is just 6% — This means → these assets are naturally decoupled from the AI cycle, offering genuine diversification.
U.S. value has outperformed growth by 10 percentage points this year, the strongest relative showing since 2022.
04

Japan's stock market — what justifies further gains?

Japanese corporate ROE — return on equity, a measure of how much profit a company earns with shareholders' capital — has reached a record 12%. BofA attributes this to governance reforms and policy support.
This reflects a structural shift, not merely a cyclical bounce: global manufacturing indicators are flat, yet Japanese profitability keeps improving.
Japanese equities have risen nearly 40% over roughly the past year.
05

Listed PE managers: down sharply — are they worth a look now?

Listed private-equity manager stocks have rallied 17% recently but remain 25–35% below their all-time highs. BofA calls them a contrarian opportunity.
Preferred names include Ares Management, KKR and Blue Owl Capital.
Risks flagged: AI disruption of traditional investing, prior vintage-year overvaluation and weak investor re-commitment appetite. BofA also expects private-credit fund redemption requests to drop sharply in Q3.
06

S&P 500 technicals — what's the picture?

BofA's technical strategist says the S&P 500 has broken above a multi-month trading range, supporting a year-end target of 8,000–8,540 — roughly 3–10% upside from the report's writing date.
The bullish setup holds as long as the index stays above 7,504 support. In plain terms = stay above that line and the chart stays constructive; break it and caution is warranted.

Content is for reference only, not financial advice.